Updated recommendations on human papillomavirus (HPV) vaccines : 9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule.: HP40-157/2017E-PDF
"In February 2015, a nine-valent human papillomavirus vaccine (HPV9) (Gardasil®9, Merck Canada, Inc.) was authorized for use in Canada. The purpose of this statement is to summarize information on this vaccine and to provide evidence-based recommendations on its use in the context of recommendations for all HPV vaccines currently authorized for use in Canada. In addition, this statement will clarify minimum intervals between doses of HPV vaccines for two-dose and three-dose HPV immunization schedules"--Introduction, p. 7.
Permanent link to this Catalogue record:
|Department/Agency|| Canada. Public Health Agency of Canada. |
Canada. National Advisory Committee on Immunization.
|Title||Updated recommendations on human papillomavirus (HPV) vaccines : 9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule.|
|Variant title|| At head of title: Advisory committee statement (ACS) - National Advisory Committee on Immunization (NACI) |
9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule
|Other language editions||[French]|
|Earlier edition||Updated recommendations on human papillomavirus (HPV) vaccines|
|Electronic document|| |
Archived information is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact the authoring department to request a format other than those available.
Note: The URLs contained in this/these document(s) may no longer be functionalHaving trouble opening this document?
|Note(s)|| Issued also in HTML format. |
Issued also in French under title: Recommandations mises à jour sur les vaccins contre le virus du papillome humain (VPH) : vaccin nonavalent contre le VPH et précisions sur les intervalles minimums entre les doses dans le calendrier d'immunisation contre le VPH.
Includes bibliographical references.
|Publishing information||[Ottawa] : Public Health Agency of Canada, 2017.|
|Catalogue number|| |
|Departmental catalogue number||Pub.: 160384|
|Subject terms||Sexually transmitted diseases, Immunization|
- Date modified: